NCT00331344View on ClinicalTrials.gov

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

mitoxantrone hydrochloride

Given IV

DRUG

ixabepilone

Given IV

DRUG

prednisone

Given orally

Trial Locations (2)

53792

University of Wisconsin Hospital and Clinics, Madison

94143-0875

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00331344 - Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy | Biotech Hunter | Biotech Hunter